Uganda AIDS Commission Seeks Shs300 Billion to Address HIV Drug Shortage Amid US Aid Cuts

Kampala, Uganda – The Uganda AIDS Commission (UAC) has appealed for Shs300 billion to cover a critical funding gap for HIV/AIDS drugs and medical supplies following cuts in U.S. aid.

While appearing before the Parliamentary Committee on Health, UAC’s Director of Planning, Mr. Nelson Musoba, warned that over 1.9 million HIV patients in Uganda are at risk of treatment disruptions if the government does not step in to fill the void.

“This is the time for the government to take full leadership of the HIV response to ensure that the gains made against the pandemic are not reversed,” Mr. Musoba emphasized.

Uganda’s fight against HIV/AIDS has long relied on international support, with the United States being a key donor. However, a recent presidential order from the U.S. government has led to significant reductions in funding, jeopardizing access to essential antiretroviral (ARV) drugs, HIV test kits, and prevention programs.

The Shs300 billion requested by UAC is intended to mitigate the shortfall and ensure continuous access to life-saving treatment. Without immediate government intervention, healthcare facilities across the country may struggle to provide medication, leading to increased HIV-related deaths and new infections.

Health experts and civil society organizations have echoed UAC’s call, urging the Ugandan government to increase domestic funding for HIV/AIDS programs to reduce dependency on foreign aid.Uganda has made significant progress in the fight against HIV/AIDS, with infections dropping and more patients accessing treatment. 

However, the current funding crisis could reverse these gains, putting millions at risk and overwhelming the healthcare system.

The Parliamentary Committee on Health is now reviewing the UAC’s request, as stakeholders push for urgent action to secure sustainable funding for Uganda’s HIV response.